# First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-line-single-agent-treatment-with-gefitinib-in-patients-with-advanced-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Seiji Niho,Kaoru Kubota,Kōichi Goto,Kiyotaka Yoh,Hironobu Ohmatsu,Ryutaro Kakinuma,Nagahiro Saijo,Yutaka Nishiwaki |
| Citations | 163 |
| DOI | 10.1200/jco.2005.02.5825 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.02.5825?role=tab |
| OpenAlex ID | https://openalex.org/W2119248047 |
| PMID | 16382114 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Seiji Niho](https://scholariq.org/researchers/seiji-niho/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.